Ezetimibe (Vietnamese Wikipedia)

Analysis of information sources in references of the Wikipedia article "Ezetimibe" in Vietnamese language version.

refsWebsite
Global rank Vietnamese rank
4th place
7th place
2nd place
2nd place
399th place
214th place
1st place
1st place
low place
5,154th place
3,912th place
5,012th place
5th place
13th place
3,258th place
6,247th place

clincalc.com

doi.org

  • Awad K, Mikhailidis DP, Katsiki N, Muntner P, Banach M (tháng 3 năm 2018). “Effect of Ezetimibe Monotherapy on Plasma Lipoprotein(a) Concentrations in Patients with Primary Hypercholesterolemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials”. Drugs. 78 (4): 453–462. doi:10.1007/s40265-018-0870-1. PMID 29396832.
  • Savarese G, De Ferrari GM, Rosano GM, Perrone-Filardi P (tháng 12 năm 2015). “Safety and efficacy of ezetimibe: A meta-analysis”. Int. J. Cardiol. 201: 247–52. doi:10.1016/j.ijcard.2015.08.103. PMID 26301648.
  • Phan BA, Dayspring TD, Toth PP (2012). “Ezetimibe therapy: mechanism of action and clinical update”. Vasc Health Risk Manag. 8: 415–27. doi:10.2147/VHRM.S33664. PMC 3402055. PMID 22910633.
  • Cannon, Christopher P. (ngày 18 tháng 6 năm 2015). “Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes”. New England Journal of Medicine. 372 (25): 2387–2397. doi:10.1056/NEJMoa1410489. PMID 26039521.
  • Alenghat, Francis J.; Davis, Andrew M. (2019). “Management of Blood Cholesterol”. JAMA. doi:10.1001/jama.2019.0015. ISSN 0098-7484. PMID 30715135.
  • Catapano AL, Reiner Z, De Backer G, và đồng nghiệp (tháng 7 năm 2011). “ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)”. Atherosclerosis. 217 (1): 3–46. doi:10.1016/j.atherosclerosis.2011.06.011. PMID 21882396.
  • Teramoto T, Sasaki J, Ishibashi S, và đồng nghiệp (2013). “Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan -2012 version”. J. Atheroscler. Thromb. 20 (6): 517–23. doi:10.5551/jat.15792. PMID 23665881.
  • Expert Dyslipidemia Panel of the International Atherosclerosis Society Panel members (2014). “An International Atherosclerosis Society Position Paper: global recommendations for the management of dyslipidemia--full report”. J Clin Lipidol. 8 (1): 29–60. doi:10.1016/j.jacl.2013.12.005. PMID 24528685.

drugs.com

  • “Ezetimibe Monograph for Professionals”. Drugs.com (bằng tiếng Anh). American Society of Health-System Pharmacists. Truy cập ngày 13 tháng 4 năm 2019.
  • “Ezetimibe (Zetia) Use During Pregnancy”. Drugs.com (bằng tiếng Anh). Truy cập ngày 13 tháng 4 năm 2019.

medicaid.gov

data.medicaid.gov

nice.org.uk

nih.gov

pubmed.ncbi.nlm.nih.gov

  • Awad K, Mikhailidis DP, Katsiki N, Muntner P, Banach M (tháng 3 năm 2018). “Effect of Ezetimibe Monotherapy on Plasma Lipoprotein(a) Concentrations in Patients with Primary Hypercholesterolemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials”. Drugs. 78 (4): 453–462. doi:10.1007/s40265-018-0870-1. PMID 29396832.
  • Savarese G, De Ferrari GM, Rosano GM, Perrone-Filardi P (tháng 12 năm 2015). “Safety and efficacy of ezetimibe: A meta-analysis”. Int. J. Cardiol. 201: 247–52. doi:10.1016/j.ijcard.2015.08.103. PMID 26301648.
  • Phan BA, Dayspring TD, Toth PP (2012). “Ezetimibe therapy: mechanism of action and clinical update”. Vasc Health Risk Manag. 8: 415–27. doi:10.2147/VHRM.S33664. PMC 3402055. PMID 22910633.
  • Cannon, Christopher P. (ngày 18 tháng 6 năm 2015). “Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes”. New England Journal of Medicine. 372 (25): 2387–2397. doi:10.1056/NEJMoa1410489. PMID 26039521.
  • Alenghat, Francis J.; Davis, Andrew M. (2019). “Management of Blood Cholesterol”. JAMA. doi:10.1001/jama.2019.0015. ISSN 0098-7484. PMID 30715135.
  • Catapano AL, Reiner Z, De Backer G, và đồng nghiệp (tháng 7 năm 2011). “ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)”. Atherosclerosis. 217 (1): 3–46. doi:10.1016/j.atherosclerosis.2011.06.011. PMID 21882396.
  • Teramoto T, Sasaki J, Ishibashi S, và đồng nghiệp (2013). “Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan -2012 version”. J. Atheroscler. Thromb. 20 (6): 517–23. doi:10.5551/jat.15792. PMID 23665881.
  • Expert Dyslipidemia Panel of the International Atherosclerosis Society Panel members (2014). “An International Atherosclerosis Society Position Paper: global recommendations for the management of dyslipidemia--full report”. J Clin Lipidol. 8 (1): 29–60. doi:10.1016/j.jacl.2013.12.005. PMID 24528685.

ncbi.nlm.nih.gov

web.archive.org

worldcat.org